Daniel K. Crawford

1.1k total citations
21 papers, 916 citations indexed

About

Daniel K. Crawford is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pathology and Forensic Medicine. According to data from OpenAlex, Daniel K. Crawford has authored 21 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel K. Crawford's work include Nicotinic Acetylcholine Receptors Study (8 papers), Receptor Mechanisms and Signaling (7 papers) and Multiple Sclerosis Research Studies (6 papers). Daniel K. Crawford is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (8 papers), Receptor Mechanisms and Signaling (7 papers) and Multiple Sclerosis Research Studies (6 papers). Daniel K. Crawford collaborates with scholars based in United States and France. Daniel K. Crawford's co-authors include Seema K. Tiwari‐Woodruff, Mario Mangiardi, Daryl L. Davies, Ronald L. Alkana, James R. Trudell, Rhusheet Patel, Sienmi Du, Rhonda R. Voskuhl, Spencer M. Moore and Matthew M. Goddeeris and has published in prestigious journals such as Journal of Biological Chemistry, Brain and Neurology.

In The Last Decade

Daniel K. Crawford

20 papers receiving 903 citations

Peers

Daniel K. Crawford
Bilal E. Kerman United States
Simon M. G. Braun Switzerland
Kathryn K. Bercury United States
Verónica T. Cheli United States
Timothy P. Kegelman United States
Mario Mangiardi United States
Jelle Praet Belgium
Daniel K. Crawford
Citations per year, relative to Daniel K. Crawford Daniel K. Crawford (= 1×) peers Qiao‐Ling Cui

Countries citing papers authored by Daniel K. Crawford

Since Specialization
Citations

This map shows the geographic impact of Daniel K. Crawford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel K. Crawford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel K. Crawford more than expected).

Fields of papers citing papers by Daniel K. Crawford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel K. Crawford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel K. Crawford. The network helps show where Daniel K. Crawford may publish in the future.

Co-authorship network of co-authors of Daniel K. Crawford

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel K. Crawford. A scholar is included among the top collaborators of Daniel K. Crawford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel K. Crawford. Daniel K. Crawford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vincent, Thomas L., et al.. (2024). Genetics of cystogenesis in base-edited human organoids reveal therapeutic strategies for polycystic kidney disease. Cell stem cell. 31(4). 537–553.e5. 25 indexed citations
2.
Crawford, Daniel K., Jasper Mullenders, Johanna Pott, et al.. (2021). Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids. Journal of Cystic Fibrosis. 20(3). 436–442. 57 indexed citations
3.
Crawford, Daniel K., et al.. (2020). ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins. Journal of Pharmacology and Experimental Therapeutics. 374(2). 264–272. 38 indexed citations
4.
Crawford, Daniel K., Phillip Vanlandingham, Susan Schneider, & Matthew M. Goddeeris. (2020). Intravitreal administration of small molecule read-through agents demonstrate functional activity in a nonsense mutation mouse model. Experimental Eye Research. 201. 108274–108274.
5.
Ravikumar, Brinda, Daniel K. Crawford, Tammy Dellovade, et al.. (2016). Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis. Neuropharmacology. 108. 229–237. 40 indexed citations
6.
Crawford, Daniel K., Dongzi Yu, Frédéric Bernard, et al.. (2014). ONO-4641 (Ceralifimod) Prevents Evoked Potential Deficits in an Animal Model of Multiple Sclerosis (P1.218). Neurology. 82(10_supplement). 1 indexed citations
7.
Kumar, Shalini, Rhusheet Patel, Spencer M. Moore, et al.. (2013). Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis. Neurobiology of Disease. 56. 131–144. 107 indexed citations
8.
Mangiardi, Mario, Daniel K. Crawford, Xiaoyu Xia, et al.. (2010). An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis. Brain Pathology. 21(3). 263–278. 84 indexed citations
9.
Trudell, James R., et al.. (2010). Molecular targets and mechanisms for ethanol action in glycine receptors. Pharmacology & Therapeutics. 127(1). 53–65. 46 indexed citations
10.
Crawford, Daniel K., Mario Mangiardi, Bingbing Song, et al.. (2010). Oestrogen receptor β ligand: a novel treatment to enhance endogenous functional remyelination. Brain. 133(10). 2999–3016. 110 indexed citations
11.
Trudell, James R., et al.. (2009). Loop 2 Structure in Glycine and GABAA Receptors Plays a Key Role in Determining Ethanol Sensitivity. Journal of Biological Chemistry. 284(40). 27304–27314. 33 indexed citations
12.
Crawford, Daniel K., Mario Mangiardi, & Seema K. Tiwari‐Woodruff. (2009). Assaying the functional effects of demyelination and remyelination: Revisiting field potential recordings. Journal of Neuroscience Methods. 182(1). 25–33. 55 indexed citations
13.
Crawford, Daniel K., et al.. (2009). Functional recovery of callosal axons following demyelination: a critical window. Neuroscience. 164(4). 1407–1421. 88 indexed citations
14.
Trudell, James R., et al.. (2008). Targets for ethanol action and antagonism in Loop 2 of the extracellular domain of glycine receptors. Journal of Neurochemistry. 106(3). 1337–1349. 30 indexed citations
15.
Crawford, Daniel K., et al.. (2008). Roles for Loop 2 Residues of α1 Glycine Receptors in Agonist Activation. Journal of Biological Chemistry. 283(41). 27698–27706. 17 indexed citations
16.
Crawford, Daniel K., et al.. (2007). Evidence that ethanol acts on a target in Loop 2 of the extracellular domain of α1 glycine receptors. Journal of Neurochemistry. 102(6). 2097–2109. 58 indexed citations
17.
Davies, Daryl L., Daniel K. Crawford, James R. Trudell, & Ronald L. Alkana. (2005). Propofol acts on different sites than ethanol and butanol in recombinant glycine receptors: Evidence from pressure studies. International Congress Series. 1283. 312–314. 1 indexed citations
18.
Davies, Daryl L., Daniel K. Crawford, James R. Trudell, S. John Mihic, & Ronald L. Alkana. (2004). Multiple sites of ethanol action in α1 and α2 glycine receptors suggested by sensitivity to pressure antagonism. Journal of Neurochemistry. 89(5). 1175–1185. 29 indexed citations
19.
Alkana, R.L., Daniel K. Crawford, & Daryl L. Davies. (2004). A NEW HYPOTHESIS FOR A MECHANISM OF ETHANOL ACTION IN GLYCINE RECEPTORS INVOLVING INCREASED AGONIST ACTIVATION.. Alcoholism Clinical and Experimental Research. 28(Supplement). 36A–36A. 1 indexed citations
20.
Davies, Daryl L., James R. Trudell, S. John Mihic, Daniel K. Crawford, & Ronald L. Alkana. (2003). Ethanol Potentiation of Glycine Receptors Expressed in Xenopus Oocytes Antagonized by Increased Atmospheric Pressure. Alcoholism Clinical and Experimental Research. 27(5). 743–755. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026